These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 7726968

  • 21. Clinical case of the month. 3-year-old boy presenting with a hand rash. Juvenile dermatomyositis.
    Kendrick CG, Poole JC, Nicotri T, Gedalia A, Lopez FA.
    J La State Med Soc; 2004; 156(5):235-9; quiz 240. PubMed ID: 15554092
    [Abstract] [Full Text] [Related]

  • 22. Outcome in juvenile dermatomyositis.
    Chowdhary V, Wakhlu A, Agarwal A, Misra R.
    Indian Pediatr; 2002 Oct; 39(10):931-5. PubMed ID: 12428038
    [Abstract] [Full Text] [Related]

  • 23. Early hydroxychloroquine macular toxicity.
    Warner AE.
    Arthritis Rheum; 2001 Aug; 44(8):1959-61. PubMed ID: 11508449
    [Abstract] [Full Text] [Related]

  • 24. Antimalarial myopathy in amyopathic dermatomyositis.
    Foulke G, Baccon J, Marks JG, Clarke JT.
    Arch Dermatol; 2012 Sep; 148(9):1100-1. PubMed ID: 22986884
    [No Abstract] [Full Text] [Related]

  • 25. Juvenile dermatomyositis in Thai children.
    Singalavanija S, Liamsuwan S, Limpongsanurak W, Raungsuwan S.
    J Med Assoc Thai; 2001 Nov; 84(11):1527-33. PubMed ID: 11853294
    [Abstract] [Full Text] [Related]

  • 26. Ten-year experience of juvenile dermatomyositis: a retrospective study.
    Chiu SK, Yang YH, Wang LC, Chiang BL.
    J Microbiol Immunol Infect; 2007 Feb; 40(1):68-73. PubMed ID: 17332910
    [Abstract] [Full Text] [Related]

  • 27. [Juvenile dermatomyositis and toxoplasmosis: a rare association].
    da Silva BS, Pereira RM, de Carvalho JF.
    Acta Reumatol Port; 2009 Feb; 34(3):546-50. PubMed ID: 19820679
    [Abstract] [Full Text] [Related]

  • 28. Recurrent psoriatic onychoperiostitis induced by hydroxychloroquine.
    Sibilia J, Cribier B, Javier RM, Pflumio F, Kuntz JL.
    Rev Rhum Engl Ed; 1995 Dec; 62(11):795-7. PubMed ID: 8869222
    [Abstract] [Full Text] [Related]

  • 29. [Juvenile dermatomyositis: 4 case studies].
    Marcil T, Khoudri I, Meziane M, Beqqal K, Khatibi I, Hassam B, Afifi Y, Benzekri L.
    Arch Pediatr; 2008 Sep; 15(9):1443-5. PubMed ID: 18676126
    [Abstract] [Full Text] [Related]

  • 30. [Juvenile dermatomyositis: diagnosis and treatment].
    Gissinger-Prévot S, Figarella-Branger D, Mancini J, Chabrol B.
    Arch Pediatr; 2008 Jan; 15(1):50-3. PubMed ID: 18164188
    [Abstract] [Full Text] [Related]

  • 31. Hydroxychloroquine does not decrease serum methotrexate concentrations in children with juvenile idiopathic arthritis.
    Haapasaari J, Kautiainen H, Isomäki H, Hakala M.
    Arthritis Rheum; 2005 May; 52(5):1621-2. PubMed ID: 15880808
    [No Abstract] [Full Text] [Related]

  • 32. Hydroxychloroquine myopathy.
    Richards AJ.
    J Rheumatol; 1998 Aug; 25(8):1642-3. PubMed ID: 9712114
    [Abstract] [Full Text] [Related]

  • 33. Cyclosporin a therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 cases.
    Zeller V, Cohen P, Prieur AM, Guillevin L.
    J Rheumatol; 1996 Aug; 23(8):1424-7. PubMed ID: 8856623
    [Abstract] [Full Text] [Related]

  • 34. Juvenile dermatomyositis: a retrospective review of a 30-year experience.
    Peloro TM, Miller OF, Hahn TF, Newman ED.
    J Am Acad Dermatol; 2001 Jul; 45(1):28-34. PubMed ID: 11423831
    [Abstract] [Full Text] [Related]

  • 35. A case of hydroxychloroquine induced pruritus.
    Gül U, Cakmak SK, Kiliç A, Gönül M, Bilgili S.
    Eur J Dermatol; 2006 Jul; 16(5):586-7. PubMed ID: 17101489
    [No Abstract] [Full Text] [Related]

  • 36. [Acute generalized exanthematous pustulosis induced by hydroxychloroquine].
    Assier H, Auffret N, Beltzer-Garelly E, Faures-Quenet B, Binet O.
    Ann Dermatol Venereol; 1993 Jul; 120(11):848-50. PubMed ID: 8210143
    [No Abstract] [Full Text] [Related]

  • 37. [Contribution to dermatomyositis in childhood].
    Rohde B, Jänner M.
    Hautarzt; 1967 Feb; 18(2):56-61. PubMed ID: 6031176
    [No Abstract] [Full Text] [Related]

  • 38. Hyperpigmentation of the skin due to hydroxychloroquine.
    Rood MJ, Vermeer MH, Huizinga TW.
    Scand J Rheumatol; 2008 Feb; 37(2):158. PubMed ID: 18415776
    [No Abstract] [Full Text] [Related]

  • 39. Case report: A case of resistant anti-SAE1 dermatomyositis with severe periorbital edema after hydroxychloroquine that responded to adalimumab.
    Farhat M, Soutou B.
    Int J Rheum Dis; 2024 Mar; 27(3):e15125. PubMed ID: 38501604
    [No Abstract] [Full Text] [Related]

  • 40. Hydroxychloroquine-induced pigmentation in two patients with systemic lupus erythematosus.
    Reynaert S, Setterfield J, Black MM.
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):487-8. PubMed ID: 16643169
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.